Market Overview:
The global nedaplatin (CAS 95734-82-0) market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing demand for nedaplatin (CAS 95734-82-0) in oncology treatments, and growing number of approvals for nedaplatin (CAS 95734-82-0). Based on type, the global nedaplatin (CAS 95734-82-0) market is segmented into 10mg/vial, 100mg/vial, and others. The 10mg/vial segment is expected to account for a major share of the global market during the forecast period. This can be attributed to its low price and easy availability compared with other types of vials. Based on application, the global nedaplatin (CAS 95734-82_0)market is segmented into hospital pharmacies, retail pharmacies, online pharmacies. The hospital pharmacies segment is expected to account for a major share of the global market duringthe forecast period owingtoits large customer baseand widespread distribution network across regions.
 Industry Outlook.svg)
Product Definition:
Nedaplatin is a platinum-based chemotherapy drug. It is used to treat ovarian cancer, small cell lung cancer, and other cancers.
10mg/Vial:
Nedaplatin (CAS 95734-82-0) is an organic intermediate used in the production of a range of pharmaceutical products. The product has been developed as a replacement for carboplatin owing to its enhanced activity and specificity towards cancer cells. Carboplatin was found to be toxic and carcinogenic in nature, thus resulting in the development of nedaplatin by Cipla Ltd.
100mg/Vial:
Nedaplatin is a platinum (IV) drug. It is used in chemotherapy for cancer. Chemotherapy with Nedaplatin can be given to patients with breast, lung, or other types of cancer as well as to those who have recovered from the disease but are at risk of relapsing.
The medicine has been studied in combination with 5-fluorouracil and irinotecan; it showed promising results.
Application Insights:
The global demand for needaplatin was dominated by the hospital pharmacy segment, which accounted for over 75% of the total revenue share in 2017. The growth of this segment is directly proportional to the volume of chemotherapy drugs administered during cancer treatment. Thus, increasing number of hospital pharmacies and rising awareness about Nedaplatin as a vital drug for cancer patients are expected to drive demand over the forecast period.
Nedaplatin 10 mg/vial is used in various oncology indications such as lung, breast and colorectal cancers among others. Increasing adoption due to its effectiveness and low toxicity makes it suitable for use across all age groups thus supporting its market growth during the study period. However, high cost may pose a challenge while adopting needaplatin therapy hence influencing market size negatively in near future but not restricting market growth at an estimated CAGR from 2018 to 2030 ¢â€š¹2%.
Regional Analysis:
North America held the largest market share in 2017 owing to the presence of a large number of manufacturers and distributors. The region will retain its dominant position throughout the forecast years due to increasing awareness about cancer treatment options, high disposable income, and availability of effective treatment methods.
Asia Pacific is expected to register lucrative growth over the forecast period owing to rising demand for generic drugs in this region. Increasing healthcare expenditure along with growing penetration of international pharmaceutical companies is also contributing towards regional growth.
In addition, favorable government initiatives pertaining change in regulations & policies regarding export/import operations are further anticipated favorably impact global nedaplatin (CAS 95734-82-0) market growth during 2018 - 2030 time frame.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the nedaplatin market. According to a study by the World Health Organization (WHO), it is estimated that there will be around 18 million new cases of cancer in 2030, and this number is expected to rise further in future. This will create a high demand for nedaplatin and other platinum-based drugs, thereby driving the growth of the nedaplatin market.
- Rising awareness about chemotherapy: There has been an increase in awareness about chemotherapy among patients and healthcare professionals in recent years. This has led to an increase in demand for platinum-based drugs such as nedaplatin, which are used for treating various types of cancers.
- Technological advancements: The development of new technologies has helped improve the efficacy and safety profile of nedaplatin and other platinum-based drugs. For instance, targeted therapies such as immunotherapy are being increasingly used to treat various types of cancers, including those that are resistant to traditional treatments like chemotherapy regimens containing platinum-based drugs like nedaplatin .This is likely to drive demand for these drugs in future..
Scope Of The Report
Report Attributes
Report Details
Report Title
Nedaplatin (CAS 95734-82-0) Market Research Report
By Type
10mg/Vial, 100mg/Vial, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Qilu Pharma, Aosaikang Pharma, Simcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Nedaplatin (CAS 95734-82-0) Market Report Segments:
The global Nedaplatin (CAS 95734-82-0) market is segmented on the basis of:
Types
10mg/Vial, 100mg/Vial, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qilu Pharma
- Aosaikang Pharma
- Simcare
 Market Overview.svg)
Highlights of The Nedaplatin (CAS 95734-82-0) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10mg/Vial
- 100mg/Vial
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nedaplatin (CAS 95734-82-0) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nedaplatin is a platinum-based chemotherapy drug used to treat various types of cancer. It works by killing cancer cells.
Some of the key players operating in the nedaplatin (cas 95734-82-0) market are Qilu Pharma, Aosaikang Pharma, Simcare.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nedaplatin (CAS 95734-82-0) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nedaplatin (CAS 95734-82-0) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nedaplatin (CAS 95734-82-0) Market - Supply Chain
4.5. Global Nedaplatin (CAS 95734-82-0) Market Forecast
4.5.1. Nedaplatin (CAS 95734-82-0) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nedaplatin (CAS 95734-82-0) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nedaplatin (CAS 95734-82-0) Market Absolute $ Opportunity
5. Global Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Type
5.3.1. 10mg/Vial
5.3.2. 100mg/Vial
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nedaplatin (CAS 95734-82-0) Demand Share Forecast, 2019-2026
9. North America Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Type
9.7.1. 10mg/Vial
9.7.2. 100mg/Vial
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nedaplatin (CAS 95734-82-0) Demand Share Forecast, 2019-2026
10. Latin America Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Type
10.7.1. 10mg/Vial
10.7.2. 100mg/Vial
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nedaplatin (CAS 95734-82-0) Demand Share Forecast, 2019-2026
11. Europe Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Type
11.7.1. 10mg/Vial
11.7.2. 100mg/Vial
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nedaplatin (CAS 95734-82-0) Demand Share, 2019-2026
12. Asia Pacific Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Type
12.7.1. 10mg/Vial
12.7.2. 100mg/Vial
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nedaplatin (CAS 95734-82-0) Demand Share, 2019-2026
13. Middle East & Africa Nedaplatin (CAS 95734-82-0) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nedaplatin (CAS 95734-82-0) Market Size and Volume Forecast by Type
13.7.1. 10mg/Vial
13.7.2. 100mg/Vial
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nedaplatin (CAS 95734-82-0) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nedaplatin (CAS 95734-82-0) Market: Market Share Analysis
14.2. Nedaplatin (CAS 95734-82-0) Distributors and Customers
14.3. Nedaplatin (CAS 95734-82-0) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Qilu Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Aosaikang Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Simcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
